MEDICINAL cannabis is likely to provide a significant opportunity for the community pharmacy sector in Australia, with at least six manufacturers expected to take part in next year's APP conference.
Conference chairman Kos Sclavos revealed the strong interest from the medicinal cannabis sector in a presentation at APP on Fri, saying some had wanted to take part this year but it was decided the time was not right, with protocols yet to be developed.
He said he believed 95% of medicinal cannabis products would not be on the PBS, with the items effectively like the introduction of a new therapeutic class with applications in epilepsy, multiple sclerosis and palliative care.
Sclavos also highlighted the potential of private professional pharmacy programs as more and more private medicines launch.
"For manufacturers, pharmacist-facilitated support can ensure compliance and persistence in the critical first few months of therapy."
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Mar 17